Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients

<p>Demographics and Baseline Characteristics</p>

Gardado en:

Detalles Bibliográficos
Autor Principal:	Cloud P. Paweletz (14960112) (author)
Outros autores:	Grace A. Heavey (16495683) (author), Yanan Kuang (16495686) (author), Emily Durlacher (16495689) (author), Thian Kheoh (16495692) (author), Richard C. Chao (16495695) (author), Alexander I. Spira (16495698) (author), Konstantinos Leventakos (16495701) (author), Melissa L. Johnson (16019536) (author), Sai-Hong Ignatius Ou (15023025) (author), Gregory J. Riely (14961725) (author), Kenna Anderes (15123501) (author), Wenjing Yang (16495704) (author), James G. Christensen (15123507) (author), Pasi A. Jänne (14954872) (author)
Publicado:	2025
Subjects:	Cancer Clinical Research and Trials Methods and Technology Imaging Liquid Biopsy Precision Medicine
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares